No Brand Drugs For Iowa Medicaid Patients: 8th Circ.

Law360, New York (August 20, 2009, 6:23 PM EDT) -- A federal appeals court has rejected a plan by the state of Iowa to offer brand-name drugs, rather than generics, to Medicaid patients under an arrangement in which the state thought it could get branded drugs cheaper by utilizing government rebates.

The U.S. Court of Appeals for the Eighth Circuit ruled Wednesday that the plan ran afoul of Medicaid regulations, denying a petition by the Iowa Department of Human Services to review the rejection of the plan by the Centers for Medicare and Medicaid Services in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.